Page 427 - Binder2
P. 427

Most profoundly, she regained something that medicine
               rarely restores: a sense of control.




               What This Case Reveals

               Rebecca’s story is not a one-off success—it’s a preview.


               It illustrates the paradigm shift edible biologics represent:

                   •  From supervision to self-management.
                   •  From scarcity to scalability.
                   •  From trauma to tolerance.

               This is what edible immunology offers:


                   •  Delivery that disappears into daily life.
                   •  Therapies that fit the patient, instead of requiring
                       the patient to rearrange everything around them.
                   •  Clinical interventions that empower rather than
                       burden.

               It also shows what’s possible when new technology is
               paired with human-centered design:

                   •  Lower cost of goods means lower out-of-pocket
                       burden.
                   •  No cold chain means wider global applicability.
                   •  Oral administration means broader adherence
                       and less clinician bottleneck.
                   •  AI-guided production means consistency without
                       complexity.





                                          425
   422   423   424   425   426   427   428   429   430   431   432